在接受抗吸收和/或抗血管生成药物治疗的患者中评估MRONJ风险及相关因素:一项回顾性队列研究

{"title":"在接受抗吸收和/或抗血管生成药物治疗的患者中评估MRONJ风险及相关因素:一项回顾性队列研究","authors":"Ömer Ekici","doi":"10.5505/tjo.2022.3359","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":"45 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of MRONJ Risk and Associated Factors in Patients Receiving Antiresorptive and/or Antiangiogenic Drug Therapy: A Retrospective Cohort Study\",\"authors\":\"Ömer Ekici\",\"doi\":\"10.5505/tjo.2022.3359\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":42117,\"journal\":{\"name\":\"Turk Onkoloji Dergisi-Turkish Journal of Oncology\",\"volume\":\"45 1\",\"pages\":\"\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turk Onkoloji Dergisi-Turkish Journal of Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5505/tjo.2022.3359\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5505/tjo.2022.3359","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}